Development and validation of an immune gene-set based Prognostic signature in ovarian cancer

Development and validation of an immune gene-set based Prognostic signature in ovarian cancer

Background: Ovarian cancer (OV) is the most lethal gynecological cancer in women. We aim to develop a generalized, individualized immune prognostic signature that can stratify and predict overall survival for ovarian cancer. Methods: The gene expression profiles of ovarian cancer tumor tissue sample...

Full description

Bibliographic Details
Main Authors:	Sipeng Shen, Guanrong Wang, Ruyang Zhang, Yang Zhao, Hao Yu, Yongyue Wei, Feng Chen
Format:	Article
Language:	English
Published:	Elsevier 2019-02-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396418306315

Similar Items

Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma
by: Rui Shen, et al.
Published: (2021-02-01)

Development of a multi-gene-based immune prognostic signature in ovarian Cancer
by: Tiefeng Cao, et al.
Published: (2021-01-01)

Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer
by: Shibai Yan, et al.
Published: (2020-12-01)

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer
by: Yu Chen, et al.
Published: (2021-03-01)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
by: Mengjing Cui, et al.
Published: (2022-01-01)

Correction to: Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer
by: Shibai Yan, et al.
Published: (2021-01-01)

An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
by: Shi F, et al.
Published: (2021-07-01)

Bayesian variable selection for parametric survival model with applications to cancer omics data
by: Weiwei Duan, et al.
Published: (2018-11-01)

Developing and Validating an Autophagy Gene-Set-Based Prognostic Signature in Hepatocellular Carcinoma Patients
by: Zhang J, et al.
Published: (2022-11-01)

Identification and Validation of a Novel Prognostic Signature Based on Ferroptosis-Related Genes in Ovarian Cancer
by: Zhe Cheng, et al.
Published: (2023-01-01)

Validating ORR and PFS as surrogate endpoints in phase II and III clinical trials for NSCLC patients: difference exists in the strength of surrogacy in various trial settings
by: Tiantian Hua, et al.
Published: (2022-09-01)

Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer
by: Na Li, et al.
Published: (2021-02-01)

Identification and validation of immunity- and disulfidptosis-related genes signature for predicting prognosis in ovarian cancer
by: Miaojia Jin, et al.
Published: (2024-06-01)

Large-scale integration of the non-coding RNAs with DNA methylation in human cancers
by: Sipeng Shen, et al.
Published: (2023-03-01)

Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
by: Wenbiao Chen, et al.
Published: (2020-01-01)

Immune-Related Genes’ Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer
by: Bo Ding, et al.
Published: (2023-03-01)

Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes
by: Xiaoyan Shen, et al.
Published: (2022-03-01)

Identification and validation of a prognostic signature based on six immune-related genes for colorectal cancer
by: Lifeng Zheng, et al.
Published: (2024-05-01)

Development and validation of prognostic signatures of NAD+ metabolism and immune-related genes in colorectal cancer
by: Tao Ye, et al.
Published: (2024-07-01)

Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
by: Hengzi Sun, et al.
Published: (2019-09-01)

Construction and validation of a transcription factors-based prognostic signature for ovarian cancer
by: Qingyuan Cheng, et al.
Published: (2022-02-01)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
by: Sijin Sun, et al.
Published: (2020-08-01)

Transmission dynamics model and the coronavirus disease 2019 epidemic: applications and challenges
by: Guan Jinxing, et al.
Published: (2022-02-01)

Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
by: Xiao Huo, et al.
Published: (2021-05-01)

A prognostic signature based on adenosine metabolism related genes for ovarian cancer
by: Weifeng Liang, et al.
Published: (2022-11-01)

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
by: Rongjia Su, et al.
Published: (2022-05-01)

Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
by: Huaide Qiu, et al.
Published: (2020-02-01)

Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
by: Zhijing Na, et al.
Published: (2021-08-01)

Immune gene signatures as prognostic criteria for cancer patients
by: Irina Larionova, et al.
Published: (2023-08-01)

Identification and validation of a prognostic model based on immune-related genes in ovarian carcinoma
by: Min Yu, et al.
Published: (2024-10-01)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
by: Shan Hua, et al.
Published: (2022-07-01)

Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma
by: Rujia Qin, et al.
Published: (2021-07-01)

Immune-Related Long Non-coding RNA Constructs a Prognostic Signature of Ovarian Cancer
by: Xiaoyu Sun, et al.
Published: (2021-12-01)

Construction and validation of a prognostic signature based on microvascular invasion and immune-related genes in hepatocellular carcinoma
by: Hao Li, et al.
Published: (2024-11-01)

Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer
by: Sipei Nie, et al.
Published: (2023-04-01)

Mendelian Randomization With Refined Instrumental Variables From Genetic Score Improves Accuracy and Reduces Bias
by: Lijuan Lin, et al.
Published: (2021-03-01)

Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma
by: Xianghong Zhou, et al.
Published: (2020-11-01)

CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer
by: Tian Hua, et al.
Published: (2023-03-01)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
by: Yan Zhang, et al.
Published: (2021-11-01)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
by: Xiao Yang, et al.
Published: (2022-02-01)